Arsenic exposure is associated with pediatric pneumonia in rural Bangladesh: a case control study

Christine Marie George1,2, W Abdullah Brooks3,4, Joseph H Graziano5

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. cgeorg19@jhu.edu.

Insights

Childhood pneumonia, a leading cause of death, may be linked to arsenic exposure. This study found nearly double the odds of pneumonia in children with higher urinary arsenic levels, suggesting a potential risk factor.

Area of Science:

  • Environmental Health
  • Pediatric Infectious Diseases
  • Toxicology

Background:

  • Pneumonia is the leading cause of mortality in children under five globally.
  • Millions of children worldwide are exposed to elevated arsenic levels in drinking water.
  • Limited data exists on the association between arsenic exposure and respiratory infections in children.

Purpose of the Study:

  • To investigate if arsenic exposure is a risk factor for pneumonia in a pediatric population.
  • To assess the association between urinary arsenic concentrations and severe pneumonia in young children.

Main Methods:

  • A case-control study was conducted in rural Bangladesh with 153 pneumonia cases and 296 controls (28 days to 59 months).
  • Severe or very severe pneumonia was physician-diagnosed based on World Health Organization criteria.
  • Urinary arsenic levels were measured using graphite furnace atomic absorption spectrometry at hospital admission and 30 days later for cases, and once for controls.

Main Results:

  • Children with urinary arsenic concentrations above the first quartile (≥6 μg/L) had nearly double the odds of pneumonia (adjusted OR: 1.88) at hospital admission.
  • This association remained consistent at the convalescent time point (adjusted OR: 2.32).
  • Adjustments were made for factors including urinary creatinine, weight for height, breastfeeding, paternal education, age, and household size.

Conclusions:

  • Low to moderate arsenic exposure may be a significant risk factor for pneumonia in children under five.
  • This study provides novel evidence linking arsenic exposure to increased pneumonia risk in pediatric populations.
  • Findings highlight the importance of addressing arsenic contamination in drinking water to reduce childhood pneumonia burden.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
80
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
374
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K